Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

ARCA BIOPHARMA, INC.

(ABIO)
  Bericht
ÜbersichtKurseChartsNewsTermineUnternehmenFinanzenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über ARCA BIOPHARMA, INC.
04.01.Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2
04.01.ARCA biopharma, Inc. Announces Data on Gencaro Impact on Prevention of Bradycardia Publ..
2021ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
2021ARCA BIOPHARMA : Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Tr..
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021ARCA biopharma Completes Enrollment in Phase 2b Trial of COVID-19 Treatment
2021ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical T..
2021ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical T..
2021ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Up..
2021Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q3 Loss $-0.33
2021ARCA BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
2021ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months End..
2021Health Care Stocks Muted in Lead Up to Friday's Opening Bell
2021Health Care
2021ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clin..
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clin..
2021ARCA biopharma, Inc. Provides an Update on the ASPEN-COVID-19 Phase 2b Clinical Trial E..
2021ARCA BIOPHARMA : Announces Enrollment of First International Patient in Phase 2b Clinical ..
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021ARCA BIOPHARMA : Enrolls First International Patient in Phase 2b Trial of rNAPc2 to Treat ..
2021ARCA BIOPHARMA : Announces Enrollment of First International Patient in Phase 2b Clinical ..
2021ARCA Biopharma, Inc. Announces Enrollment of First International Patient in Phase 2B Cl..
2021ARCA BIOPHARMA : to Present at the Q3 Virtual Investor Summit on August 18th
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coro..
2021ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coro..
2021ARCA BIOPHARMA : Announces Second Quarter 2021 Financial Results and Provides Corporate Up..
2021ARCA BIOPHARMA : Earnings Flash (ABIO) ARCA BIOPHARMA Posts Q2 Loss $-0.34
2021ARCA BIOPHARMA : Announces Second Quarter 2021 Financial Results and Provides Corporate Up..
2021ARCA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
2021Arca Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 202..
2021ARCA BIOPHARMA : O a 36% reduction in cumulative atrial fibrillation burden with a 55% red..
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021GENCARO ATRIAL FIBRILLATION PHASE 2B : Arrhythmia and Electrophysiology
2021ARCA Biopharma, Inc Announces That the Paper Entitled Bucindolol [Gencaro] Decreases AF..
2021ARCA BIOPHARMA : Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAP..
2021ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021ARCA BIOPHARMA : Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAP..
2021ARCA biopharma, Inc. Provides Update on Aspen-Covid-19 Phase 2B Clinical Trial
2021ARCA BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
2021ARCA BIOPHARMA : to Present at Access to Giving Virtual Investor Conference on July 13th
2021ARCA BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Financial Statements an..
2021ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement
2021ARCA biopharma, Inc Announces rNAPc2 COVID-19 Patent Assignment Agreement
2021ARCA BIOPHARMA : Amendment to Bylaws (Form 8-K)
2021ARCA BIOPHARMA : AMENDED AND RESTATED BY-LAWS OF (Form 8-K)
2021ARCA BIOPHARMA, INC. : Other Events (form 8-K)
2021ARCA BIOPHARMA, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi..
2021ARCA BIOPHARMA, INC. : Other Events (form 8-K)
2021ARCA BIOPHARMA : Earnings Flash (ABIO) ARCA BIOPHARMA Posts Q1 Loss $-0.33
2021ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Up..
2021ARCA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
2021Arca Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 202..
2021ARCA BIOPHARMA : Announces First Quarter 2021 Financial Results and Provides Corporate Upd..
2021Christopher Graybill Joins ARCA as Vice President, Clinical Development
2021ARCA BIOPHARMA : Taps C. Jeff Dekker for Finance Chief
2021ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial Statements and..
2021ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
2021ARCA biopharma Announces C. Jeff Dekker as Chief Financial Officer
2021ARCA BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Shareholder Director No..
2021ARCA BIOPHARMA : Files Shelf for Up to $150 Million in Securities
2021ARCA BIOPHARMA : Announces Third Quarter 2020 Financial Results and Provides Corporate Upd..
2021ARCA BIOPHARMA : Annual Net Loss Widens
2021ARCA BIOPHARMA : Announces 2020 Financial Results and Provides Corporate Update
2021ARCA BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results o..
2021Arca Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
2021ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
2020ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial Statements and..
2020ARCA BIOPHARMA : Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Tri..
2020ARCA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2020ARCA BIOPHARMA : Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Tri..
2020ARCA biopharma, Inc. Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clini..
2020ARCA BIOPHARMA : Announces Location Change for 2020 Annual Meeting of Stockholders
2020ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Submission of Matters to..
1  2  3Weiter
Anstehende Termine für ARCA BIOPHARMA, INC.
17.03.22